feed,title,long_url,short_url
Benzinga,FDA Approves AbbVie's JAK Inhibitor Application For Active Psoriatic Arthritis,https://benzinga.com/general/biotech/21/12/24621005/fda-approves-abbvies-jak-inhibitor-application-for-active-psoriatic-arthritis,https://j.mp/3yrGbHI
